Scott Ferguson’s Celgene Corp CELG Stock Holding History

Scott Ferguson’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1,650,000	Closed	-$205M	–	19
2017 Q1	$205M	Buy	1,650,000 +305,000	+23%	+$36.5M	6.65%	2
2016 Q4	$156M	Buy	+1,345,000	New	+$150M	5.96%	5

Other funds holding CELG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Scott Ferguson's CELG Position: Q2 2017 in Review

Scott Ferguson sold out of Celgene Corp (CELG) in Q2 2017, closing a stake of 1,650,000 shares — an estimated $205M sold.

Scott Ferguson first reported a position in CELG in Q4 2016 and held it in 2 quarters. The position peaked at $205M in Q1 2017. 1,428 funds tracked by Wall St. Rank hold CELG as of Q2 2017.

Scott Ferguson reported no remaining Celgene Corp position as of Q2 2017 after selling out during the quarter.
Scott Ferguson sold 1,650,000 Celgene Corp shares in Q2 2017, an estimated $205M.
Scott Ferguson first reported a position in Celgene Corp in Q4 2016 and held it in 2 quarters.
Scott Ferguson's Celgene Corp position peaked at $205M in Q1 2017.
1,428 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2017.

Based on Sachem Head Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.